Gabapentin use in benzodiazepine dependence and detoxification.
Crockford
D
D
White
W D
WD
Campbell
B
B
D000085:Acetates / Q000627:therapeutic use*; D000525:Alprazolam / Q000009:adverse effects*; D000588:Amines; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008875:Middle Aged; D019966:Substance-Related Disorders / Q000188:drug therapy*; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D014151:Anti-Anxiety Agents; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000525:Alprazolam